Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma

Blood (2016) 128 (9): 1234–1245.

https://doi.org/10.1182/blood-2016-03-707141

Published: 2016

Includes: Supplemental data

Journal Articles

HCT-CI Has Prognostic Value in Acute, but Not Chronic Gvhd Specific Survival

Marc Poch Martell, MD, Nada Hamad, MBBS Hons, FRACP, FRCPA, Fotios V. Michelis, MDPhD, Jieun Uhm, MD, Feras Alfraih, MD, Mohamed Shanavas, MD FRACP, FRCPA, Vikas Gupta, MD FRCP, FRCPath, John Kuruvilla, MD, Jeffrey H. Lipton, MD PhD, Hans A. Messner, MD PhD, Matthew D. Seftel, MRCP, FRCPC, MPH, Dennis Kim, MDPhD

Blood (2014) 124 (21): 3915.

https://doi.org/10.1182/blood.V124.21.3915.3915

Published: 2014

Journal Articles

Steroid Failure At Day 28 After Acute Graft-Versus-Host Disease Treatment and Long-Term Outcomes Following Allogeneic Transplantation: Adverse Impact On Survival and Non-Relapse Mortality But No Increasing Risk Of Relapse

Joon Ho Moon, M.D., Ph.D., Sang Kyun Sohn, MD, PhD, Naheed Alam, MBBS, Jieun Uhm, MD, Vikas Gupta, MD, FRCP, FRCPath, Jeffrey H. Lipton, MD, PhD, Hans A. Messner, M.D./Ph.D, John Kuruvilla, MD, FRCPC, Dennis Dong Hwan Kim, MD, PhD

Blood (2013) 122 (21): 2066.

https://doi.org/10.1182/blood.V122.21.2066.2066

Published: 2013

Journal Articles

Independent Validation of Chronic Graft-Versus-Host Disease (GVHD) Grading System Proposed by the NIH Consensus Criteria in Terms of Prognostic Stratification of the Patients Developed Chronic Gvhd

Joon Ho Moon, MD, Sang Kyun Sohn, MD, Jieun Uhm, MD, Vikas Gupta, MD, FRCP, FRCPath, Jeffrey H. Lipton, MD, PhD, Hans A. Messner, M.D./Ph.D, John Kuruvilla, MD, FRCPC, Dennis Dong Hwan Kim, MD, PhD

Blood (2012) 120 (21): 1946.

https://doi.org/10.1182/blood.V120.21.1946.1946

Published: 2012

Journal Articles

Expansion of Large Granular Lymphocytes Following Allogeneic Stem Cell Transplantation: Its Association with Graft-Versus-Host Disease and Graft-Versus-Leukemia Effect.

Dong Hwan (Dennis) Kim, Ghuzayel Al-Dawsari, Chul Won Jung, Chang Hong, Suzanne Kamel-Reid, Janice Wright, Ahmed Galal, Vikas Gupta, John Kuruvilla, Jeffrey H. Lipton, Hans A. Messner

Blood (2009) 114 (22): 2253.

https://doi.org/10.1182/blood.V114.22.2253.2253

Published: 2009

Journal Articles

Identification of SEC23B as the Gene Responsible for Congenital Dyserythropoietic Anemia Type II using a Proteomic-Genomic Approach.

Paola Bianchi, Elisa Fermo, Cristina Vercellati, Carla Boschetti, Wilma Barcellini, Alessandra Iurlo, Anna Paola Marcello, Pier Giorgio Righetti, Alberto Zanella

Blood (2009) 114 (22): 4028.

https://doi.org/10.1182/blood.V114.22.4028.4028

Published: 2009

Journal Articles

HIF1 Induced Glutathione Dysregulation in Platelets Associated with Increased Risk of Vascular Disease in Chuvash Polycythemia.

Heather Gilbert, MD, Donghoon Yoon, PhD, Adelina I Sergueeva, Victor R. Gordeuk, MD, Josef T. Prchal, MD

Blood (2008) 112 (11): 1906.

https://doi.org/10.1182/blood.V112.11.1906.1906

Published: 2008

Journal Articles

Re-Evaluation of Chronic Graft-Versus-Host Disease Using National Institute of Health Consensus Criteria.

Dae-Young Kim, Je-Hwan Lee, Jung-Hee Lee, Se Hyung Kim, Sung-nam Lim, Young-Shin Lee, Young-Ah Kang, Sol-Ip Kang, Miee Seol, Seong-Gil Ryu, Kyoo-Hyung Lee

Blood (2008) 112 (11): 2239.

https://doi.org/10.1182/blood.V112.11.2239.2239

Published: 2008

Journal Articles

Late Onset Eosinophilia (beyond Day 100), Rather Than Early Onset Eosinophilia, Has a Significant Prognostic Impact on Transplant Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT).

Dong Hwan (Dennis) Kim, MD, PhD, Gizelle Popradi, MD, John Kuruvilla, MD, Vikas Gupta, MD, Mark Minden, MD, PhD, Hans A. Messner, MD, PhD, Jeffrey H. Lipton, MD, PhD

Blood (2007) 110 (11): 1062.

https://doi.org/10.1182/blood.V110.11.1062.1062

Published: 2007

Journal Articles

Time to First Acute Exacerbation Can Stratify the Patients According to Their Prognosis during Clinical Course of Chronic GVHD: Evaluation of New End-Point for Chronic GVHD.

Dong Hwan Kim, MD, Sang Kyun Sohn, MD, Kun Soo Lee, MD, Jong Gwang Kim, MD, Kyu Bo Lee, MD, Kyoo-Hyung Lee, MD, Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD

Blood (2005) 106 (11): 5335.

https://doi.org/10.1182/blood.V106.11.5335.5335

Published: 2005

Journal Articles

Risk Factor Analysis for Predicting Chronic Graft-Versus-Host Disease of Progressive or Quiescent Type in a Cohort of Patients with a History of Acute Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation.

Sang Kyun Sohn, MD, Dong Hwan Kim, MD, Jin Ho Baek, MD, Jong Gwang Kim, MD, Kyu Bo Lee, MD, Kyoo-Hyung Lee, MD, Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD

Blood (2005) 106 (11): 5337.

https://doi.org/10.1182/blood.V106.11.5337.5337

Published: 2005

NARROW

Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma

HCT-CI Has Prognostic Value in Acute, but Not Chronic Gvhd Specific Survival

Steroid Failure At Day 28 After Acute Graft-Versus-Host Disease Treatment and Long-Term Outcomes Following Allogeneic Transplantation: Adverse Impact On Survival and Non-Relapse Mortality But No Increasing Risk Of Relapse

Independent Validation of Chronic Graft-Versus-Host Disease (GVHD) Grading System Proposed by the NIH Consensus Criteria in Terms of Prognostic Stratification of the Patients Developed Chronic Gvhd

Expansion of Large Granular Lymphocytes Following Allogeneic Stem Cell Transplantation: Its Association with Graft-Versus-Host Disease and Graft-Versus-Leukemia Effect.

Identification of SEC23B as the Gene Responsible for Congenital Dyserythropoietic Anemia Type II using a Proteomic-Genomic Approach.

HIF1 Induced Glutathione Dysregulation in Platelets Associated with Increased Risk of Vascular Disease in Chuvash Polycythemia.

Re-Evaluation of Chronic Graft-Versus-Host Disease Using National Institute of Health Consensus Criteria.

Late Onset Eosinophilia (beyond Day 100), Rather Than Early Onset Eosinophilia, Has a Significant Prognostic Impact on Transplant Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT).

Time to First Acute Exacerbation Can Stratify the Patients According to Their Prognosis during Clinical Course of Chronic GVHD: Evaluation of New End-Point for Chronic GVHD.

Risk Factor Analysis for Predicting Chronic Graft-Versus-Host Disease of Progressive or Quiescent Type in a Cohort of Patients with a History of Acute Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only